ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2310건의 자료가 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1617 | Active, not recruiting | Covid-19 Vaccination in Adolescents and Children | Covid19 | Biological: Tozinameran Biological: CoronaVac Biological: CoronaVac, intradermal |
Phase 2 | The University of Hong Kong | OTHER | 1018 | All | 0 Years ~ 100 Years | Queen Mary Hospital, Hong Kong, Hong Kong, China |
| 1616 | Terminated | COVID-19 Vaccination in Rheumatic Disease Patients | Osteoarthritis | Biological: mRNA COVD19 vaccine | Early Phase 1 | Mayo Clinic | OTHER | 58 | All | 18 Years | Mayo Clinic in Rochester, Rochester, Minnesota, United States |
| 1615 | Active, not recruiting | COVID-19 Vaccination of Immunodeficient Persons (COVAXID) | Covid19 | Biological: Comirnaty (COVID-19, mRNA vaccine) | Phase 4 | Karolinska University Hospital, Karolinska Institutet | OTHER | 540 | All | 18 Years | Karolinska University Hospital, Stockholm, Huddinge, Sweden |
| 1614 | Active, not recruiting | COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults | Covid19 | Biological: hAd5-S-Fusion+N-ETSD vaccine | Phase 1 | ImmunityBio, Inc. | INDUSTRY | 35 | All | 18 Years ~ 50 Years | Khayelitsha Clinical Research Site, Khayelitsha, South Africa |
| 1613 | Completed | COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers | COVID-19 | Biological: hAd5-S-Fusion+N-ETSD vaccine | Phase 1 | ImmunityBio, Inc. | INDUSTRY | 34 | All | 18 Years ~ 55 Years | Chan Soon - Shiong Institute for Medicine, El Segundo, California, United States Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States |
| 1612 | Recruiting | COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases | Immunosuppression | Biological: COVID-19 vaccine | Phase 3 | Paul R Fortin, Canadian Institutes of Health Research (CIHR) | OTHER | 287 | All | 18 Years | Research Institute - McGill University Health Centre, Montreal, Quebec, Canada Centre de recherche du CHU de Quebec - Universite Laval, Quebec, Quebec, Canada |
| 1611 | Terminated | COVID-19 Vaccine Boosters in Patients With CKD | COVID-19 | Biological: Pfizer-BioNTech COVID-19 Vaccine Biological: MODERNA SARS-CoV-2 Vaccine |
Phase 3 | Sunnybrook Health Sciences Centre, University Health Network, Toronto, Unity Health Toronto, Scarborough General Hospital, Providence Healthcare | OTHER | 268 | All | 18 Years | Scarborough Health Network, Scarborough, Ontario, Canada University Health Network, Toronto, Ontario, Canada Sunnybrook Health Science Center, Toronto, Ontario, Canada |
